Tao Zhou
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 12
-
- Lung Cancer Diagnosis and Treatment 21
- Gastric Cancer Management and Outcomes 13
- Otorhinolaryngology top 10%
- Surgery top 10%
- Esophageal Cancer Research and Treatment 18
-
- RNA modifications and cancer 13
-
- Advanced Radiotherapy Techniques 8
-
- Hepatitis C virus research 6
-
- Hepatitis B Virus Studies 6
- Journals
- Angewandte Chemie International Edition (1 paper)Journal of Clinical Oncology (1 paper)Scientific Reports (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Tao Zhou
107 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 98
- Complementary and Manual Therapy 57
- Cancer Research 236
- Pulmonary and Respiratory Medicine 438
- Otorhinolaryngology 45
- Surgery 429
Countries citing papers authored by Tao Zhou
This map shows the geographic impact of Tao Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Zhou more than expected).
Fields of papers citing papers by Tao Zhou
This network shows the impact of papers produced by Tao Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Zhou. The network helps show where Tao Zhou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tao Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 3 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 16 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 12 | |
| 8 | 2024 | 3 | |
| 9 | 2024 | 1 | |
| 10 | 2023 | 34 | |
| 11 | 2023 | 5 | |
| 12 | 2022 | 7 | |
| 13 | 2022 | 5 | |
| 14 | 2019 | 15 | |
| 15 | 2019 | 5 | |
| 16 | 2016 | 1 | |
| 17 | 2015 | 24 | |
| 18 | 2013 | 4 | |
| 19 | A comparison of treatment with adefovir and entecavir for chronic hepatitis B in China: The 2-year results of a prospective study | 2011 | 3 |
| 20 | 2007 | 4 |
About Tao Zhou
Tao Zhou is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Hepatology, having authored 113 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (21 papers), Esophageal Cancer Research and Treatment (18 papers), Gastric Cancer Management and Outcomes (13 papers), RNA modifications and cancer (13 papers), Cancer-related molecular mechanisms research (12 papers), Advanced Radiotherapy Techniques (8 papers), Hepatitis C virus research (6 papers) and Hepatitis B Virus Studies (6 papers). The work is most often cited by research in Complementary and Manual Therapy (57 citations), Cancer Research (236 citations) and Pulmonary and Respiratory Medicine (438 citations). Tao Zhou has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Yanjing Gao, Baosheng Li, Wei Huang, Hongfu Sun, Aijun Li, Weisheng Liu, Peicheng Cao, Zhanzhan Li, Lizhang Chen and Zicheng Zhang. Their work appears in journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.